| Literature DB >> 30760028 |
Roongrit Klinjampa1, Chantacha Sitticharoon1, Xaynaly Souvannavong-Vilivong1, Chanakarn Sripong1, Issarawan Keadkraichaiwat1, Malika Churintaraphan1, Saimai Chatree1, Tripop Lertbunnaphong2.
Abstract
IMPACT STATEMENT: Neuropeptide Y (NPY) has been reported as a vasoconstrictive substance which might be associated with preeclampsia. The novel findings of this study were that Y1R, Y2R, and Y5R expressions were significantly lower in the PE than the NP group. Moreover, the NPY receptor expression ratio between the PE/NP groups was lowest for Y2R (0.27) compared to Y1R (0.42) and Y5R (0.40) suggestive of a reduction of this receptor in the preeclampsia group. Our results suggested that decreased Y2R mRNA in the PE group might be associated with abnormalities of placental angiogenesis which probably contributes to the pathophysiology of preeclampsia.Entities:
Keywords: NPY receptors; Preeclampsia; blood pressure; gene expression; neuropeptide Y
Mesh：
Substances：
Year: 2019 PMID： 30760028 PMCID： PMC6488869 DOI： 10.1177/1535370219831437
Source DB: PubMed Journal: Exp Biol Med (Maywood) ISSN： 1535-3699